Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia J Simner

Showing results (31-40 of 159) with videos related to

Pageof 16
Sort By:
The Indian Journal of Medical Research|August 29, 2025
Evaluation of the rapid lateral flow assay (LFA) for detection of five major carbapenemase enzyme families in genotypically characterised bacterial isolatesSana Rahmani, Shaoli Basu, Patricia J Simner, et al.
Journal of Clinical Microbiology|October 31, 2014
Evaluation of five chromogenic agar media and the Rosco Rapid Carb screen kit for detection and confirmation of carbapenemase production in Gram-negative bacilliPatricia J Simner, Matthew W Gilmour, Pat DeGagne, et al.
Infection Control and Hospital Epidemiology|October 3, 2017
Is There a Carbapenem MIC Cutoff Value That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem Non-Susceptible Pseudomonas and Acinetobacter Isolates?Pranita D Tamma, Ruibin Wang, Shawna Lewis, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2023
Cefepime in vivo activity against carbapenem-resistant Enterobacterales that test as cefepime susceptible or susceptible-dose dependent in vitro: implications for clinical microbiology laboratory and cliniciansAliaa Fouad, Christian M Gill, Patricia J Simner, et al.
Open Forum Infectious Diseases|March 22, 2019
Reporting Extended-Spectrum β-Lactamase Positivity May Reduce Carbapenem OverusePranita D Tamma, Sara E Cosgrove, Edina Avdic, et al.
Open Forum Infectious Diseases|May 1, 2023
Successful Treatment of Persistent <i>Stenotrophomonas maltophilia</i> Bacteremia With Cefiderocol in an InfantAlice J Hsu, Patricia J Simner, Yehudit Bergman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2019
A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant WorldPranita D Tamma, Yohei Doi, Robert A Bonomo, et al.
Clinical Chemistry|December 30, 2021
Recent Advances in Rapid Antimicrobial Susceptibility TestingRucha Datar, Sylvain Orenga, Romain Pogorelcnik, et al.
Open Forum Infectious Diseases|April 22, 2022
Geographic Variation of Infectious Disease Diagnoses Among Patients With Fever of Unknown Origin: A Systematic Review and Meta-analysisWilliam F Wright, Gayane Yenokyan, Patricia J Simner, et al.
Journal of Clinical Microbiology|August 30, 2013
Detection and identification of yeasts from formalin-fixed, paraffin-embedded tissue by use of PCR-electrospray ionization mass spectrometryPatricia J Simner, Seanne P Buckwalter, James R Uhl, et al.
Pageof 16

Showing results (31-40 of 159) with videos related to

Sort By:
Pageof 16
The Indian Journal of Medical Research|August 29, 2025
Evaluation of the rapid lateral flow assay (LFA) for detection of five major carbapenemase enzyme families in genotypically characterised bacterial isolatesSana Rahmani, Shaoli Basu, Patricia J Simner, et al.
Journal of Clinical Microbiology|October 31, 2014
Evaluation of five chromogenic agar media and the Rosco Rapid Carb screen kit for detection and confirmation of carbapenemase production in Gram-negative bacilliPatricia J Simner, Matthew W Gilmour, Pat DeGagne, et al.
Infection Control and Hospital Epidemiology|October 3, 2017
Is There a Carbapenem MIC Cutoff Value That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem Non-Susceptible Pseudomonas and Acinetobacter Isolates?Pranita D Tamma, Ruibin Wang, Shawna Lewis, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2023
Cefepime in vivo activity against carbapenem-resistant Enterobacterales that test as cefepime susceptible or susceptible-dose dependent in vitro: implications for clinical microbiology laboratory and cliniciansAliaa Fouad, Christian M Gill, Patricia J Simner, et al.
Open Forum Infectious Diseases|March 22, 2019
Reporting Extended-Spectrum β-Lactamase Positivity May Reduce Carbapenem OverusePranita D Tamma, Sara E Cosgrove, Edina Avdic, et al.
Open Forum Infectious Diseases|May 1, 2023
Successful Treatment of Persistent <i>Stenotrophomonas maltophilia</i> Bacteremia With Cefiderocol in an InfantAlice J Hsu, Patricia J Simner, Yehudit Bergman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2019
A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant WorldPranita D Tamma, Yohei Doi, Robert A Bonomo, et al.
Clinical Chemistry|December 30, 2021
Recent Advances in Rapid Antimicrobial Susceptibility TestingRucha Datar, Sylvain Orenga, Romain Pogorelcnik, et al.
Open Forum Infectious Diseases|April 22, 2022
Geographic Variation of Infectious Disease Diagnoses Among Patients With Fever of Unknown Origin: A Systematic Review and Meta-analysisWilliam F Wright, Gayane Yenokyan, Patricia J Simner, et al.
Journal of Clinical Microbiology|August 30, 2013
Detection and identification of yeasts from formalin-fixed, paraffin-embedded tissue by use of PCR-electrospray ionization mass spectrometryPatricia J Simner, Seanne P Buckwalter, James R Uhl, et al.
Pageof 16